Uncomplicated Urinary Tract Infection Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight
Emerging Uncomplicated Urinary Tract Infection therapies including ORLYNVAH (sulopenem etzadroxil/probenecid), Gepotidacin (GSK2140944), UROMUNE (MV140), LBP-EC01, and others are driving market ...